Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069901
Status:
COMPLETED
Last Update Posted:
2008-09-22
First Post:
2003-10-02
Brief Title:
Phase II CT-2103Carboplatin in Ovarian Cancer
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Organization Data
Organization:
CTI BioPharma
Class:
INDUSTRY
Study ID:
PGT201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CTI BioPharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None